Harvest Volatility Management LLC Biogen Inc. Transaction History

Harvest Volatility Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$275.25 - $318.06 $201,207 - $232,501	-731 Reduced 14.08%	4,461 $1.27 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $227,568 - $259,305	-887 Reduced 14.59%	5,192 $1.44 Million
Q4 2022 Feb 09, 2023	SELL	$252.44 - $306.72 $408,447 - $496,272	-1,618 Reduced 21.02%	6,079 $1.68 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $62,106 - $85,638	-319 Reduced 3.98%	7,697 $2.03 Million
Q2 2022 Aug 03, 2022	SELL	$187.54 - $223.02 $176,100 - $209,415	-939 Reduced 10.49%	8,016 $1.64 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1,550 - $1,953	8 Added 0.09%	8,955 $1.89 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $465,529 - $598,273	2,079 Added 30.27%	8,947 $2.15 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $722,190 - $941,815	2,552 Added 59.13%	6,868 $1.94 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $262,367 - $420,101	1,013 Added 30.67%	4,316 $1.5 Million
Q1 2021 May 06, 2021	BUY	$242.95 - $284.63 $301,743 - $353,510	1,242 Added 60.26%	3,303 $924,000
Q4 2020 Mar 08, 2021	BUY	$236.26 - $355.63 $486,931 - $732,953	2,061 New	2,061 $505,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Harvest Volatility Management LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Volatility Management LLC with notifications on news.